Tag: PQ Detour procedure
PQ Bypass completes enrolment in DETOUR II pivotal study
PQ Bypass has announced enrolment of the final subject in the company’s DETOUR II investigational device exemption (IDE) clinical trial. This milestone occurs only...
PQ Bypass receives FDA breakthrough device designation for its Detour system
PQ Bypass has announced that they received breakthrough device designation from the US Food and Drug Administration (FDA) for the Detour system. The Detour...
Positive safety and efficacy results from PQ Bypass DETOUR I study...
PQ Bypass has announced that the DETOUR I trial has met its primary safety and efficacy endpoints.
The data were presented by Dierk Scheinert,...
